← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Acorda Therapeutics, Inc.
Hawthorne, NY
$9,166,500
Total funding
12
Grants
Funding over time
peak $5.4M · FY2005–16$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
DOD$5,638,074 · 2
NIH$3,528,426 · 10
By mechanism
—$5,638,074 · 2
U01$1,366,849 · 1
R42$1,025,350 · 1
R43$940,701 · 7
R41$195,526 · 1
Investigators at Acorda Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
PHASE 2 CLINICAL TRIAL OF AC105 (MG/PEG) FOR TREATMENT OF ACUTE SPINAL CORD INJURY (SCI)$5,350,016
· FY2012 · Department of Defense
Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St$889,977
U01 · FY2016 · NS
Human Monocolonal Antibodies for CNS Remyelination$526,174
R42 · FY2002 · NS
Translational Development of Glial Growth Factor 2 (GGF2) for the Treatment of St$476,872
U01 · FY2014 · NS
Human Monocolonal Antibodies for CNS Remyelination$387,546
R42 · FY2003 · NS
TRANSLATIONAL PHARMACOLOGIC EFFICACY STUDIES OF GLIAL GROWTH FACTOR 2 (GGF2) IN SPINAL CORD INJURY MODELS AND IN THE VETERINARY CLINICAL SETTING$288,058
· FY2011 · Department of Defense
HUMAN MONOCLONAL ANTIBODIES FOR CNS REGENERATION$195,526
R41 · FY2000 · NS
Molecular Evolution of Chondroitinase ABCI for SCI$184,388
R43 · FY2005 · NS
Effects of Chondroitinase and Training in Acute SCI$156,491
R43 · FY2005 · NS
Chimeric proteins for the treatment of spinal cord injury$153,151
R43 · FY2005 · NS
Antisense Technology for Neural Protection and Repair$139,371
R43 · FY2001 · NS
Release Chondroitinase Systems for Spinal Cord Injury$107,300
R43 · FY2003 · NS
HUMAN ANTIBODIES TO PROMOTE CNS REGENERATION$100,000
R43 · FY2000 · NS
Tenascin-C-Fragments for Spinal Cord Regeneration$100,000
R43 · FY2001 · NS
Human Monocolonal Antibodies for CNS Remyelination$66,405
R42 · FY2004 · NS
Human Monocolonal Antibodies for CNS Remyelination$45,225
R42 · FY2003 · NS